Saltar al contenido
Merck

Semiquantitative and Quantitative Analyses of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Thyroid Nodules.

Journal of computer assisted tomography (2015-09-30)
Eliel Ben-David, Nader Sadeghi, M Katayoon Rezaei, Naira Muradyan, Derek Brown, Arjun Joshi, M Reza Taheri
RESUMEN

This study was aimed to determine the utility of quantitative dynamic contrast-enhanced magnetic resonance imaging (MRI) in differentiating benign and malignant lesions in patients with known thyroid gland lesions scheduled for resection. Patients scheduled for resection of a thyroid mass were prospectively enrolled. Dynamic contrast-enhanced MRI scans of the neck were performed before surgery. After resection, patients were divided into benign and malignant groups. Quantitative and semiquantitative MRI kinetic measurements of benign and malignant lesions were compared and analyzed. Twelve benign and 9 malignant lesions were identified in 19 patients. Mean Ktrans, Ve, and Kep for benign lesions were 1.69 ± 1.59 min, 0.44 ± 0.21 min, and 4.51 ± 2.96 min, respectively; for the malignant lesions, 0.96 ± 0.57 min, 0.45 ± 0.19 min, and 3.57 ± 3.53 min, respectively (P = 0.1886, 0.8036, and 0.3028, respectively). Tpeak, ERmax, slopemax, and iAUGC60 for benign lesions were 7.00 ± 8.09 seconds, 293.27 ± 141.25 seconds, 76.45 ± 65.80 seconds, and 63.46 ± 46.84, respectively; for malignant lesions, 8.11 ± 8.55 seconds, 227.6 ± 113.37 seconds, 81.17 ± 109.71 seconds, and 43.69 ± 26.19, respectively (P = 0.7525, 0.4941, 0.4474, and 0.3028, respectively). Dynamic contrast-enhanced MRI pattern of kinetics was not significantly different for benign and malignant lesions of the thyroid using quantitative or semiquantitative methods.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt hydrate, 97%